Lung Nodule Management Guidelines

Introduction to Lung Nodule Risk Stratification

The American College of Chest Physicians and British Thoracic Society recommend formal risk stratification and active management for lung nodules ≥8 mm, while nodules <6 mm have a malignancy probability <1% and do not require routine surveillance 1, 2, 3

Lung nodules <6 mm have a malignancy probability <1% and can be discharged without follow-up, according to the American College of Chest Physicians 1, 3
The British Thoracic Society and American College of Chest Physicians guidelines focus active management on nodules ≥8 mm on CT, with a malignancy probability of 9.7% for ≥8 mm and 16.9% for ≥300 mm³ 1, 3
For nodules 6-8 mm, optional 12-month CT surveillance may be considered depending on risk factors, as recommended by the American College of Chest Physicians 2

Age is a significant risk factor, with each year increasing the odds of malignancy (OR 1.04 per year), according to the British Thoracic Society and American College of Chest Physicians 2, 4
Smoking history substantially increases risk (OR 2.2-7.9), as stated by the British Thoracic Society and American College of Chest Physicians 2, 4
Family history of lung cancer and history of cancer >5 years prior also increase malignancy probability, as noted by the British Thoracic Society 4

Spiculation is a strong predictor of malignancy (OR 2.54-2.8), according to the British Thoracic Society 3, 4
Upper lobe location increases risk (OR 1.82-2.2), as stated by the British Thoracic Society and American College of Chest Physicians 2, 4
Growth on serial imaging, defined as ≥25% volume change, requires escalation, as recommended by the American College of Chest Physicians 3

Calcification patterns, such as diffuse, central, laminated, or popcorn calcification, indicate benignity regardless of size, according to the American College of Chest Physicians 3
Perifissural location and macroscopic fat content are also indicative of benign etiology, as noted by the British Thoracic Society and American College of Chest Physicians 3, 4

For nodules ≥8 mm, calculate formal malignancy probability using the Brock model, as recommended by the American College of Chest Physicians 2, 3
Low-risk nodules (<10%) can proceed with CT surveillance at 3 months, 12 months, and 24 months if stable, according to the American College of Chest Physicians 2, 3
Intermediate-risk nodules (10-70%) require FDG-PET/CT, followed by risk recalculation using the Herder model, as stated by the American College of Chest Physicians 2, 3
High-risk nodules (>70%) should proceed to surgical resection or non-surgical treatment as presumptive localized lung cancer, as recommended by the American College of Chest Physicians 2, 3

Do not order routine surveillance for isolated nodules <6 mm, as this exposes patients to unnecessary radiation without proven benefit, according to the American College of Chest Physicians 1
Do not rely on PET-CT for nodules <8 mm, as sensitivity is inadequate for small nodules, as stated by the American College of Chest Physicians 2, 3
Do not assume all nodules in patients with known cancer are metastases—evaluate each nodule individually, as recommended by the British Thoracic Society and American College of Chest Physicians 3, 4